Valuation: Bristol-Myers Squibb Company

Capitalization 127B 109B 99.05B 94.99B 173B 11,701B 180B 1,164B 466B 5,580B 476B 466B 19,931B P/E ratio 2026 *
12.5x
P/E ratio 2027 * 12.5x
Enterprise value 153B 132B 120B 115B 210B 14,140B 217B 1,406B 563B 6,743B 576B 563B 24,084B EV / Sales 2026 *
3.25x
EV / Sales 2027 * 3.22x
Free-Float
67.93%
Yield 2026 *
4.03%
Yield 2027 * 4.15%
1 day-0.87%
1 week+1.68%
Current month-0.06%
1 month+8.17%
3 months+19.98%
6 months+33.50%
Current year+15.55%
1 week 60.43
Extreme 60.43
62.89
1 month 59.23
Extreme 59.23
62.89
Current year 52.06
Extreme 52.06
62.89
1 year 42.52
Extreme 42.52
63.33
3 years 39.35
Extreme 39.35
71.06
5 years 39.35
Extreme 39.35
81.44
10 years 39.35
Extreme 39.35
81.44
Manager TitleAgeSince
Chief Executive Officer 55 31/10/2023
Director of Finance/CFO 58 19/11/2019
Compliance Officer - 30/09/2023
Director TitleAgeSince
Chairman 55 31/03/2024
Director/Board Member 61 31/03/2016
Director/Board Member 71 20/02/2017
Change 5d. change 1-year change 3-years change Capi.($)
+1.81%+1.68%+4.86%-10.06% 127B
-0.41%-2.46%+10.15%+215.16% 897B
-0.59%+0.05%+48.29%+59.27% 591B
+1.00%+4.09%+13.68%+51.35% 418B
-0.65%-1.95%+17.58%+31.70% 368B
+0.09%+0.05%+25.34%+40.74% 313B
-0.57%-0.89%+26.96%+60.26% 312B
+0.38%-1.78%+29.95%+12.54% 297B
+0.60%-1.32%+21.49%+61.52% 204B
+0.26%+0.75%+29.18%+82.83% 184B
Average -0.29%-0.41%+22.75%+60.53% 371.07B
Weighted average by Cap. -0.25%-0.71%+23.03%+87.01%

Financials

2026 *2027 *
Net sales 47.12B 40.52B 36.77B 35.27B 64.4B 4,344B 66.72B 432B 173B 2,072B 177B 173B 7,399B 45.78B 39.37B 35.72B 34.26B 62.57B 4,220B 64.82B 420B 168B 2,013B 172B 168B 7,188B
Net income 10.26B 8.82B 8B 7.67B 14.02B 945B 14.52B 94.01B 37.64B 451B 38.5B 37.67B 1,610B 10.13B 8.71B 7.9B 7.58B 13.84B 934B 14.34B 92.84B 37.17B 445B 38.02B 37.2B 1,590B
Net Debt 26.45B 22.74B 20.64B 19.79B 36.15B 2,438B 37.45B 242B 97.08B 1,163B 99.28B 97.15B 4,153B 20.52B 17.65B 16.01B 15.36B 28.05B 1,892B 29.06B 188B 75.32B 902B 77.03B 75.38B 3,222B
Logo Bristol-Myers Squibb Company
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 69.1% of net sales.
Employees
32,500
Date Price Change Volume
05/03/26 61.45 $ -1.41% 315,278
04/03/26 62.33 $ +1.81% 12,345,037
03/03/26 61.22 $ -1.80% 12,425,292
02/03/26 62.34 $ -0.05% 17,627,534
27/02/26 62.37 $ +2.08% 20,742,639
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
62.33USD
Average target price
62.16USD
Spread / Average Target
-0.27%

Quarterly revenue - Rate of surprise